APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
65 hedge funds and large institutions have $214M invested in Aptose Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $277M → $214M (-$63.7M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
65
Holding in Top 10
3
Calls
$1.59M
Puts
$463K
Top Buyers
| 1 | +$31.2M | |
| 2 | +$16.5M | |
| 3 | +$10.1M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$4.3M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.68M |
Top Sellers
| 1 | -$48M | |
| 2 | -$8.99M | |
| 3 | -$6.23M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.38M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$2.94M |